Tekmira Pharmaceuticals (TKMR) Stock Up on Rumored Takeover

Shares of Tekmira Pharmaceuticals Corp. (TKMR) were up +1.97 or +9.97 percent to $21.72 per share in Thursday’s premarket. The company was featured in an article in the UK’s Daily Mail as a potential takeover target following last week’s news of Intermune’s (ITMN) takeover by Swiss pharmaceutical giant Roche. Tekmira stock closed at $19.75 per Read the full article... Read the rest of Tekmira Pharmaceuticals (TKMR) Stock Up on Rumored Takeover at InvestorGuide.com .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.